MeiraGTx Holdings (MGTX) Net Income (2017 - 2025)
MeiraGTx Holdings posted quarterly Net Income of $23.7 million for Q4 2025, up 169.96% year-on-year from $8.8 million in Q4 2024, and up 148.4% on a QoQ basis from -$49.0 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Net Income data on file, last reported at $23.7 million in Q4 2025.
- For the quarter ending Q4 2025, Net Income rose 169.96% year-over-year to $23.7 million; the trailing twelve-month figure through Dec 2025 stood at -$116.3 million (up 32.88% YoY), and the FY2025 full-year result was -$116.3 million, up 32.88% from the prior year.
- Net Income for Q4 2025 stood at $23.7 million, up from -$49.0 million in the prior quarter.
- Across five years, Net Income topped out at $23.7 million in Q4 2025 and bottomed at -$49.0 million in Q3 2025.
- The 5-year median for Net Income is -$34.1 million (2023), against an average of -$31.6 million.
- The widest annual swing landed in 2022, when Net Income sank 459.0%; it then surged 169.96% in 2025.
- A 5-year view of Net Income shows it stood at -$7.8 million in 2021, then tumbled by 459.0% to -$43.5 million in 2022, then dropped by 7.21% to -$46.7 million in 2023, then gained by 27.4% to -$33.9 million in 2024, then jumped by 169.96% to $23.7 million in 2025.
- The last three Net Income figures came in at $23.7 million (Q4 2025), -$49.0 million (Q3 2025), and -$47.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 23.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.70 Mn |
| Sep 30, 2025 | -48.96 Mn |
| Jun 30, 2025 | -47.42 Mn |
| Mar 31, 2025 | -43.67 Mn |
| Dec 31, 2024 | -33.87 Mn |
| Sep 30, 2024 | -42.21 Mn |
| Jun 30, 2024 | -48.34 Mn |
| Mar 31, 2024 | -48.93 Mn |
| Dec 31, 2023 | -46.65 Mn |
| Sep 30, 2023 | -35.62 Mn |
| Jun 30, 2023 | -31.49 Mn |
| Mar 31, 2023 | -34.28 Mn |
| Dec 31, 2022 | -43.52 Mn |
| Sep 30, 2022 | -24.41 Mn |
| Jun 30, 2022 | -23.80 Mn |
| Mar 31, 2022 | -28.80 Mn |
| Dec 31, 2021 | -7.79 Mn |
| Sep 30, 2021 | -22.58 Mn |
| Jun 30, 2021 | -20.47 Mn |
| Mar 31, 2021 | -22.00 Mn |
| Dec 31, 2020 | -13.12 Mn |
| Sep 30, 2020 | -6.43 Mn |
| Jun 30, 2020 | -25.42 Mn |
| Mar 31, 2020 | -14.92 Mn |
| Dec 31, 2019 | -5.05 Mn |
| Sep 30, 2019 | -10.46 Mn |
| Jun 30, 2019 | -20.82 Mn |
| Mar 31, 2019 | -20.70 Mn |
| Dec 31, 2018 | -21.06 Mn |
| Sep 30, 2018 | -15.42 Mn |
| Jun 30, 2018 | -29.98 Mn |
| Mar 31, 2018 | -18.05 Mn |
| Dec 31, 2017 | 17.44 Mn |
| Sep 30, 2017 | -8.83 Mn |
| Jun 30, 2017 | -7.63 Mn |